This opinion cites 19 cases:
ASTRAZENECA AB v. Mylan Laboratories, Inc. , 265 F. Supp. 2d 213 ( 2003 )
SmithKline Beecham Corp. v. Geneva Pharmaceuticals, Inc. , 287 F. Supp. 2d 576 ( 2002 )
Papasan v. Allain , 106 S. Ct. 2932 ( 1986 )
Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd. , 450 F. Supp. 2d 757 ( 2006 )
Pfizer Inc. v. Ranbaxy Laboratories Ltd. , 321 F. Supp. 2d 612 ( 2004 )
Aventis Pharma Deutschland GMBH v. Lupin Ltd. , 403 F. Supp. 2d 484 ( 2005 )
Biospherics, Incorporated v. Forbes, Incorporated Caroline Waxler , 151 F.3d 180 ( 1998 )
Rodime Plc v. Seagate Technology, Inc., Defendant-Cross , 174 F.3d 1294 ( 1999 )
Allergan, Inc. And Allergan Sales, Inc. v. Alcon Laboratories, Inc., Alcon Research, Ltd., and Alcon Universal, Ltd., and Bausch & Lomb, Incorporated , 324 F.3d 1322 ( 2003 )
Portia Bass v. E.I. Dupont De Nemours & Company, Portia Bass v. E.I. Dupont De Nemours & Company, Portia Bass v. E.I. Dupont De Nemours & Company , 324 F.3d 761 ( 2003 )
Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. v. Royce Laboratories, Inc. , 69 F.3d 1130 ( 1995 )
Bell Atlantic Corp. v. Twombly , 127 S. Ct. 1955 ( 2007 )
Khoury v. Meserve , 268 F. Supp. 2d 600 ( 2003 )
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc. , 267 F. Supp. 2d 545 ( 2003 )
Warner-Lambert Company v. Apotex Corp., Apotex, Inc., and Torpharm, Inc. , 316 F.3d 1348 ( 2003 )
Glaxo, Inc., and Glaxo Group Limited v. Novopharm, Ltd. , 110 F.3d 1562 ( 1997 )
Daniel L. Veney v. T v. Wyche Darnley R. Hodge, Superintendent , 293 F.3d 726 ( 2002 )
mylan-laboratories-incorporated-v-raj-matkari-dilip-shah-raju-vegesna , 7 F.3d 1130 ( 1993 )
phonometrics-inc-v-hospitality-franchise-systems-inc-now-known-as , 203 F.3d 790 ( 2000 )
